INBS — INTELLIGENT BIO SOLUTIONS INC.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1725430 ·
Last close
$1.56
Market Cap
$5.17M
52W High
$24.90
52W Low
$1.35
ADV30
44,248
Next earnings
—
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,391,835 758,004 -2,682,747 -2,658,302 13,621,675 5,929,871 6,269,147
Jun 2026 1,145,802 536,583 -3,964,307 -3,907,667 11,941,836 3,992,312 6,651,010
Mar 2026 1,060,802 535,381 -2,941,901 -2,862,712 14,862,792 6,862,204 6,111,476
Dec 2025 896,774 459,739 -2,608,591 -2,677,590 17,653,042 740,371 6,763,231

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,927,222
Investing CF
$-85,573
Financing CF
$14,983,706
CapEx
$-361,535
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.53
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-74,964,040
Inventory
$418,577
Receivables
$1,674,493
ST Investments
—
EBIT TTM
$-12,401,018
Pretax Income TTM
$-12,468,672
Interest Exp TTM
$67,654
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,495,213
EBITDA
$-11,098,566
Free Cash Flow
$-6,795,072
Enterprise Value
$1,465,992
Total Cash
$5,929,871
Total Debt
$1,788,432
Shares Out
3,316,803
Trailing EPS
$-8.44
Book Value
$2.29
ROE
-225.3%
ROA
-64.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 4,215,175 -12,309,530 -12,430,975 11,941,836 6,651,010 5,510,835 -11,927,222
Jun 2025 3,052,532 -10,459,096 -10,568,733 8,249,786 5,435,962 2,996,136 -9,677,313
Jun 2024 3,111,781 -10,283,174 -10,156,759 13,778,863 5,595,672 8,329,350 -9,571,569
Jun 2023 1,256,872 -8,436,563 -10,631,720 10,354,612 6,667,614 3,798,984 -7,377,378
Jun 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$4,215,175
NetIncome TTM
$-12,430,975
OpCashFlow TTM
—
Assets (Latest)
$14,862,792
Forward EPS
$0.35

Peers — same industry

TickerNameMarket CapLastDaily %
WOK WORK Medical Technology Group LTD $5.26M $1.19 —
IVF INVO Fertility, Inc. $5.47M $2.18 —
USAQ QHSLab, Inc. $5.52M $0.37 —
MHUAF Meihua International Medical Technologies Co., Ltd. $4.71M $5.50 —
NDRA ENDRA Life Sciences Inc. $5.88M $3.92 —

News headlines (Yahoo Finance, 1h cache)

Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth
2026-11-10 13:30 · Yahoo
Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12
2026-11-04 13:30 · Yahoo
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
2026-09-09 12:30 · Yahoo
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
2026-09-01 12:31 · Yahoo
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
2026-08-11 12:30 · Yahoo
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
2026-07-23 12:30 · Yahoo
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
2026-07-21 12:30 · Yahoo
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
2026-05-13 12:30 · Yahoo
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
2026-06-04 12:30 · Yahoo
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
2026-06-02 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.